BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

672 related articles for article (PubMed ID: 19196838)

  • 1. Compliance with osteoporosis treatment guidelines in postmenopausal women.
    Mountjoy CR; Shrader SP; Ragucci KR
    Ann Pharmacother; 2009 Feb; 43(2):242-50. PubMed ID: 19196838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: an 18-month, multicenter, open-label, prospective study.
    Adachi JD; Hanley DA; Lorraine JK; Yu M
    Clin Ther; 2007 Sep; 29(9):2055-67. PubMed ID: 18035204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physician and patient perceptions on the use of vitamin D and calcium in osteoporosis treatment: a European and Latin American perspective.
    Resch H; Walliser J; Phillips S; Wehren LE; Sen SS
    Curr Med Res Opin; 2007 Jun; 23(6):1227-37. PubMed ID: 17559732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoporosis: evaluation of screening patterns in a primary-care group practice.
    Cohen K; Maier D
    J Clin Densitom; 2008; 11(4):498-502. PubMed ID: 18835537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone mineral density measurement and treatment for osteoporosis in older individuals with fractures: a gap in evidence-based practice guideline implementation.
    Feldstein A; Elmer PJ; Orwoll E; Herson M; Hillier T
    Arch Intern Med; 2003 Oct; 163(18):2165-72. PubMed ID: 14557214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of teriparatide in increasing bone mineral density in postmenopausal women with osteoporosis--an Indian experience.
    Sethi BK; Chadha M; Modi KD; Kumar KM; Mehrotra R; Sriram U
    J Assoc Physicians India; 2008 Jun; 56():418-24. PubMed ID: 18822620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteodensitometry in healthy postmenopausal women.
    Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoporosis and vertebral compression fractures-continued missed opportunities.
    Freedman BA; Potter BK; Nesti LJ; Giuliani JR; Hampton C; Kuklo TR
    Spine J; 2008; 8(5):756-62. PubMed ID: 18343730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Underuse of procedures for diagnosing osteoporosis and of therapies for osteoporosis in older nursing home residents.
    Gupta G; Aronow WS
    J Am Med Dir Assoc; 2003; 4(4):200-2. PubMed ID: 12837141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Raloxifene in clinical practice. Results of the non-interventional study CORAL (COmpliance with RALoxifene)].
    Rosa J; Vanuga P; Payer J; Svobodník A
    Vnitr Lek; 2008 Mar; 54(3):217-9, 221-4. PubMed ID: 18522288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-reported compliance with osteoporosis medication-qualitative aspects and correlates.
    Vytrisalova M; Blazkova S; Palicka V; Vlcek J; Cejkova M; Hala T; Pavelka K; Koblihova H
    Maturitas; 2008; 60(3-4):223-9. PubMed ID: 18774663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening and treatment of glucocorticoid-induced osteoporosis in rheumatoid arthritis patients in an urban multispecialty practice.
    Ledwich LJ; Clarke K
    J Clin Rheumatol; 2009 Mar; 15(2):61-4. PubMed ID: 19265346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physician practices of bone density testing and drug prescribing to prevent or treat osteoporosis during androgen deprivation therapy.
    Tanvetyanon T
    Cancer; 2005 Jan; 103(2):237-41. PubMed ID: 15597384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of a strategy for the management of accompanying osteoporosis after inpatient treatment of fragility fractures].
    Bahrs C; Türk A; Eingartner C; Weise K; Rolauffs B; Stuby F
    Z Orthop Unfall; 2008; 146(1):52-8. PubMed ID: 18324582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoporosis management: physicians' recommendations and womens' compliance following osteoporosis testing.
    Cole RP; Palushock S; Haboubi A
    Women Health; 1999; 29(1):101-15. PubMed ID: 10427644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and treatment of osteoporosis.
    Sweet MG; Sweet JM; Jeremiah MP; Galazka SS
    Am Fam Physician; 2009 Feb; 79(3):193-200. PubMed ID: 19202966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consultative DXA reporting improves guideline-driven quality of care-implications for increasing DXA reimbursement.
    Oppermann B; Ayoub W; Newman E; Wood GC; Olenginski TP
    J Clin Densitom; 2010; 13(3):315-9. PubMed ID: 20605498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Missed opportunities in patients with osteoporosis and distal radius fractures.
    Freedman BA; Potter BK; Nesti LJ; Cho T; Kuklo TR
    Clin Orthop Relat Res; 2007 Jan; 454():202-6. PubMed ID: 17006362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary biliary cirrhosis is not an additional risk factor for bone loss in women receiving regular calcium and vitamin D supplementation: a controlled longitudinal study.
    Benetti A; Crosignani A; Varenna M; Giussani CS; Allocca M; Zuin M; Podda M; Battezzati PM
    J Clin Gastroenterol; 2008 Mar; 42(3):306-11. PubMed ID: 18223492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoporosis pharmacotherapy and counseling services in US ambulatory care clinics: opportunities for multidisciplinary interventions.
    Teschemaker A; Lee E; Xue Z; Wutoh AK
    Am J Geriatr Pharmacother; 2008 Dec; 6(5):240-8. PubMed ID: 19161926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.